Aspar Pharmaceuticals Ltd Recalls Ibuprofen and Ibucalm 200mg Tablets Due to Packaging Defect

What Happened

Aspar Pharmaceuticals Ltd has issued a Class 3 medicines recall for specific batches of Ibuprofen 200mg tablets and Ibucalm 200mg tablets. The recall was initiated as a precautionary measure following the discovery of foil perforations in some of the blister packs.

Which Products Are Affected

The recall involves products distributed under the following liveries:

• Brand/Livery Names: Aspar, Almus, and Numark
• Product Names: Ibuprofen 200mg Tablets and Ibucalm 200mg Tablets
• Recall Identifier: EL(26)A/07

Specific batches distributed under these brands are affected by the packaging defect.

What You Should Do

Consumers should check their medication to determine if it belongs to the Aspar, Almus, or Numark brands. While the recall is a precautionary measure, individuals should contact their healthcare provider or the point of purchase for further guidance on affected batches and potential returns. Detailed information regarding the specific batch numbers can be found through the official MHRA alert portal.

Why This Matters

Foil perforations in blister packaging can compromise the integrity of the medication, potentially exposing the tablets to air or moisture, which may affect the product’s quality or stability.

Source

Information provided by the MHRA (Medicines and Healthcare products Regulatory Agency).